HD-OPM Archive
Topics › Nuts, fish, coffee, tea, cocoa & other foods

Okinawan purple sweet potato: lower glycemic impact than white potato (Blue Zones)

Louis Nervegna · Jun 20, 2025 · ♥ 4 reactions · 1 comments · original Facebook post
Nuts, fish, coffee, tea, cocoa & other foodsCarbs, fiber, sugar & whole grainsMediterranean, DASH, MIND & plant-forward diets
↻ This is a repost. The main version (highest ranked) is Okinawan purple sweet potato: a low-glycemic-load staple of the Okinawan diet · Jun 08, 2025.
AI summary & key facts

Louis shares a Blue Zones description of the Okinawan purple sweet potato, a longtime island staple that is described as not spiking blood sugar as much as white potato and rich in anthocyanins. It is a promotional recipe post without cited studies.

Much healthier than white potatoes. This is probably the healthiest potato.

#potatoesHD #okinawaHD #sweetpotatoesHD

Shared from Blue Zones · original post

One of the pillars of the Okinawan diet, Okinawan imo is a supercharged purple sweet potato, a cousin of the common yellow-orange varieties that has been an island staple since the 17th century. Despite its saccharine flavor, it does not spike blood sugar as much as a regular white potato. Like other sweet potatoes, it contains an antioxidant called sporamin, which possesses a variety of potent antiaging properties. The purple version contains higher levels than its orange and yellow cousins. This superfood is high in complex carbs, has a surprisingly low glycemic load, and packs an antioxidant punch with anthocyanin (the compound that makes blueberries blue). (Info from Dan Buettner's best-selling cookbook, #BlueZonesKtichen.)

This Easy Homemade Purple Sweet Potato Gnocchi with Pesto recipe from the Blue Zones Meal Planner is a fun and tasty way to eat more imo and brighten up your dinner table.

Get the full recipe:

meals.bluezones.comThe Blue Zones Meal Plannermeals.bluezones.com

#bluezones #bluezoneslife #livebetterlonger #longevity #purplesweetpotato #imo #bluezonesdiet

← newer: Generic statins are cheap, so big pharma is not getting richolder: Video explains why ApoB beats LDL-C for risk and why the two →